Clinical Trials Insight: 700030558
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 28 May 2008
At a glance
- Drugs Dextromethorphan/quinidine (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Avanir Pharmaceuticals
- 28 May 2008 Status changed from recruiting to in progress, according to an Avanir media release.
- 28 May 2008 Top-line results have been reported in April 2008 in an Avanir media release.
- 13 Feb 2008 New trial record.